Targeting the Adipose Tissue in COVID-19.
作者信息
Malavazos Alexis Elias, Corsi Romanelli Massimiliano Marco, Bandera Francesco, Iacobellis Gianluca
机构信息
Endocrinology Unit, Clinical Nutrition and Cardiovascular Prevention Service, IRCCS Policlinico San Donato, Milan, Italy.
Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, Italy.
出版信息
Obesity (Silver Spring). 2020 Jul;28(7):1178-1179. doi: 10.1002/oby.22844. Epub 2020 May 21.
Abstract
摘要
相似文献
1
Targeting the Adipose Tissue in COVID-19.针对新冠病毒肺炎中的脂肪组织
Obesity (Silver Spring). 2020 Jul;28(7):1178-1179. doi: 10.1002/oby.22844. Epub 2020 May 21.
2
Possible Role of Adipose Tissue and the Endocannabinoid System in Coronavirus Disease 2019 Pathogenesis: Can Rimonabant Return?脂肪组织和内源性大麻素系统在2019冠状病毒病发病机制中的潜在作用：利莫那班能否回归？
Obesity (Silver Spring). 2020 Sep;28(9):1580-1581. doi: 10.1002/oby.22916. Epub 2020 Aug 6.
3
Epicardial Fat Inflammation in Severe COVID-19.重症新型冠状病毒肺炎中的心外膜脂肪炎症
Obesity (Silver Spring). 2020 Dec;28(12):2260-2262. doi: 10.1002/oby.23019. Epub 2020 Oct 15.
4
Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury?心外膜脂肪组织：是新冠病毒诱导的心脏损伤的“燃料”吗？
Eur Heart J. 2020 Jun 21;41(24):2334-2335. doi: 10.1093/eurheartj/ehaa474.
5
Obesity, inflammation and COVID-19.肥胖、炎症与2019冠状病毒病
Swiss Med Wkly. 2020 Aug 19;150:w20349. doi: 10.4414/smw.2020.20349. eCollection 2020 Aug 10.
6
There is a Relationship Between Obesity and Coronavirus Disease 2019 but More Information is Needed.肥胖与2019冠状病毒病之间存在关联，但仍需更多信息。
Obesity (Silver Spring). 2020 Aug;28(8):1371-1373. doi: 10.1002/oby.22883. Epub 2020 Jul 6.
7
Does epicardial fat contribute to COVID-19 myocardial inflammation?心外膜脂肪会导致新型冠状病毒肺炎心肌炎症吗？
Eur Heart J. 2020 Jun 21;41(24):2333. doi: 10.1093/eurheartj/ehaa471.
8
Increased Severity of COVID-19 in People with Obesity: Are We Overlooking Plausible Biological Mechanisms?肥胖人群中新冠病毒疾病（COVID-19）病情加重：我们是否忽略了合理的生物学机制？
Obesity (Silver Spring). 2020 Aug;28(8):1374. doi: 10.1002/oby.22887. Epub 2020 Jul 6.
9
COVID-19 Ventilatory Phenotypes and Obesity: Is There a Relationship?新冠病毒肺炎通气表型与肥胖：存在关联吗？
Obesity (Silver Spring). 2020 Aug;28(8):1370. doi: 10.1002/oby.22877. Epub 2020 Jul 10.
10
Obesity and covid-19: the role of the food industry.肥胖与新冠疫情：食品行业的作用
BMJ. 2020 Jul 14;370:m2813. doi: 10.1136/bmj.m2813.
引用本文的文献
1
Gut microbiota in post-acute COVID-19 syndrome: not the end of the story.新冠后急性综合征中的肠道微生物群：故事尚未结束。
Front Microbiol. 2024 Dec 24;15:1500890. doi: 10.3389/fmicb.2024.1500890. eCollection 2024.
2
Perindopril decreases angiotensin-converting enzyme 2 (ACE2) expression in human adipocytes exposed to SARS-CoV-2 S1 spike protein.培哚普利降低暴露于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）S1刺突蛋白的人脂肪细胞中血管紧张素转换酶2（ACE2）的表达。
Narra J. 2024 Aug;4(2):e746. doi: 10.52225/narra.v4i2.746. Epub 2024 May 2.
3
Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-Metabolism.应对癌症患者的新冠后急性综合征，从内脏肥胖和肌少脂变到全身炎症：对心脏肿瘤代谢的影响
Biomedicines. 2024 Jul 24;12(8):1650. doi: 10.3390/biomedicines12081650.
4
Sociodemographic Profile and Risk Factors for the Evolution of Patients with COVID-19 in ICUs in Brazil: A Cross-Sectional Study.巴西 ICU 中 COVID-19 患者的社会人口学特征和演变的危险因素：一项横断面研究。
ScientificWorldJournal. 2024 Jul 15;2024:2927407. doi: 10.1155/2024/2927407. eCollection 2024.
5
Obesity as a Risk Factor for Complications and Mortality in Individuals with SARS-CoV-2: A Systematic Review.肥胖作为 SARS-CoV-2 感染者并发症和死亡的风险因素：系统综述。
Nutrients. 2024 Feb 16;16(4):543. doi: 10.3390/nu16040543.
6
The impact of body mass index on long-term survival after ICU admission due to COVID-19: A retrospective multicentre study.体重指数对新型冠状病毒肺炎所致重症监护病房收治后长期生存的影响：一项回顾性多中心研究
Crit Care Resusc. 2023 Nov 22;25(4):182-192. doi: 10.1016/j.ccrj.2023.10.004. eCollection 2023 Dec.
7
Aminoacyl-tRNA synthetase interactions in SARS-CoV-2 infection.SARS-CoV-2 感染中的氨酰-tRNA 合成酶相互作用。
Biochem Soc Trans. 2023 Dec 20;51(6):2127-2141. doi: 10.1042/BST20230527.
8
Pericardial Fat Is Associated With Less Severe Multiorgan Failure Over Time in Patients With Coronavirus Disease-19: The Maastricht Intensive Care COVID Cohort.心包脂肪与 COVID-19 患者多器官衰竭严重程度降低有关：马斯特里赫特重症监护 COVID 队列。
J Thorac Imaging. 2024 May 1;39(3):W32-W39. doi: 10.1097/RTI.0000000000000732. Epub 2023 Aug 25.
9
Relationship between anthropometric and body composition parameters and anti-SARS-CoV-2 specific IgG titers in females vaccinated against COVID-19 according to the heterologous vaccination course: A cohort study.根据异源疫苗接种方案，女性接种 COVID-19 疫苗后的人体测量学和身体成分参数与抗 SARS-CoV-2 特异性 IgG 滴度的关系：一项队列研究。
PLoS One. 2023 Jun 13;18(6):e0287128. doi: 10.1371/journal.pone.0287128. eCollection 2023.
10
Lifestyle Changes during the SARS-CoV-2 Pandemic as Predictors of BMI Changes among Men and Women in Poland.SARS-CoV-2 大流行期间生活方式的改变可预测波兰男女 BMI 的变化。
Nutrients. 2023 May 23;15(11):2427. doi: 10.3390/nu15112427.
本文引用的文献
1
COVID 19 and the Patient with Obesity - The Editors Speak Out.2019冠状病毒病与肥胖患者——编辑发声
Obesity (Silver Spring). 2020 May;28(5):847. doi: 10.1002/oby.22808. Epub 2020 Apr 1.
2
Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19.新冠病毒病患者中的肾素-血管紧张素-醛固酮系统抑制剂
N Engl J Med. 2020 Apr 23;382(17):1653-1659. doi: 10.1056/NEJMsr2005760. Epub 2020 Mar 30.
3
COVID-19 and diabetes: Can DPP4 inhibition play a role?2019冠状病毒病与糖尿病：二肽基肽酶4抑制作用能否发挥作用？
Diabetes Res Clin Pract. 2020 Apr;162:108125. doi: 10.1016/j.diabres.2020.108125. Epub 2020 Mar 26.
4
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.血管紧张素受体阻滞剂可作为治疗 SARS-CoV-2 的候选药物。
Drug Dev Res. 2020 Aug;81(5):537-540. doi: 10.1002/ddr.21656. Epub 2020 Mar 4.
5
DPP4-directed therapeutic strategies for MERS-CoV.针对中东呼吸综合征冠状病毒（MERS-CoV）的二肽基肽酶4（DPP4）导向治疗策略。
Lancet Infect Dis. 2014 Feb;14(2):100-1. doi: 10.1016/S1473-3099(13)70696-0.
6
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.二肽基肽酶 4 是新兴的人类冠状病毒-EMC 的功能性受体。
Nature. 2013 Mar 14;495(7440):251-4. doi: 10.1038/nature12005.
7
Obesity and the risk and outcome of infection.肥胖与感染的风险和结局。
Int J Obes (Lond). 2013 Mar;37(3):333-40. doi: 10.1038/ijo.2012.62. Epub 2012 May 1.
8
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.血管紧张素转换酶2是严重急性呼吸综合征冠状病毒的功能性受体。
Nature. 2003 Nov 27;426(6965):450-4. doi: 10.1038/nature02145.
Zotero 插件